Announcements

Date	Title
16 Jul 24, 07:00	Ananda Developments - Notice of AGM	View
15 Jul 24, 07:00	Ananda Developments - Publication of Annual Report and Accounts	View
11 Jul 24, 07:00	Ananda Developments - Invitation to Investor Evening	View
26 Jun 24, 07:00	Ananda Developments - Promising Results from Cardiac Fibrosis Studies	View
11 Jun 24, 13:27	Ananda Developments - Extension of Mark Ling as Senior Statutory Auditor	View
31 May 24, 07:00	Ananda Developments - Ananda joins cannabinoid R&D Group	View
30 May 24, 07:00	Ananda Developments - Quarterly Trading Statement to 30 April 2024	View
14 May 24, 07:00	Ananda Developments - Ananda Presentation to LSX Conference 2024	View
02 May 24, 12:00	Ananda Developments - Response to FSA-FSS Cannabidiol Safety Assessment	View
21 Mar 24, 07:00	Ananda Developments - Establishment of Scientific Advisory Board	View
28 Feb 24, 07:00	Ananda Developments - Endometriosis Trial Drug Supply Agreement Signed	View
26 Feb 24, 12:00	Ananda Developments - Ananda presenting at Master Investor Show	View
26 Feb 24, 07:00	Ananda Developments - Quarterly Trading Statement to 31 January 2024	View
06 Feb 24, 07:00	Ananda Developments - Appointment of Adviser	View
23 Jan 24, 07:00	Ananda Developments - Appointment of Scientific Advisers	View
14 Dec 23, 07:00	Ananda Developments - Ananda Launches New Interactive Investor Hub	View
29 Nov 23, 14:39	Ananda Developments - Quarterly Trading Statement to 31 October 2023	View
14 Nov 23, 07:00	Ananda Developments - Drug Supply Agreement Signed	View
08 Nov 23, 07:30	Ananda Developments - Investor Presentation via Investor Meet Company	View
08 Nov 23, 07:00	Ananda Developments - THC Oil Patent Application Filed	View